Delivery Order SPE2DB24D1205-SPE2DB25FCRWB

Award Date 11/22/24
Potential Completion Date 11/25/24
Potential Value $3.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,572.06 Firm Fixed Price Delivery Order is for the supply of 4,561,952,911 units of Tamsulosin HCl 0.4 mg capsules. The contract has an ultimate completion date of August 28, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,707,544 units of Tamsulosin HCL 0.4 mg capsules. The firm-fixed-price, $1,667.08 delivery order contract has an ultimate completion date of December 13, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,183.37 firm fixed-price delivery order is for the supply of Tamsulosin HCL 0.4 mg capsules, with a completion date of September 18, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,092.88 firm fixed-price delivery order is for the supply of 4,566,719,603 capsules of 0.4 mg Tamsulosin HCl, a medication used to treat benign prostatic hyperplasia. The contract has an ultimate completion date of December 16, 2024 and was awarded on December 13, 2024. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,583.25 firm fixed-price delivery order is for the supply of Tamsulosin HCl 0.4 mg capsules, a medication used to treat an enlarged prostate. The contract has a completion date of November 8, 2024 and was awarded on November 7, 2022. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,074.38 firm-fixed-price delivery order is for the supply of 1,000 capsules of Tamsulosin HCl 0.4 mg, a medication used to treat enlarged prostate. The contract has an ultimate completion date of September 9, 2024 and was awarded on September 6, 2024. Amerisourcebergen holds several Indefinite Delivery...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order with a ceiling value of $1,504.35 for the procurement of 1,000 capsules of Tamsulosin HCl 0.4 mg. The award was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on July 11, 2024, with a performance period through July 12, 2024. The contract is a firm fixed-price agreement and does not utilize any set-aside designations. AmerisourceBergen holds a $999,999,999 Indefinite...
This federal contract award is a delivery order worth $6,657.11 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The order is for the supply of 1,000 capsules of the prescription drug Tamsulosin HCl 0.4 mg. The contract has a firm-fixed price pricing type and a completion date of September 9, 2024. It is not set aside for any specific business category. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,102.10, is a delivery order for the supply of 1,000 capsules of Tamsulosin HCL 0.4 mg, a medication used to treat symptoms of an enlarged prostate. The contract has a firm fixed price and an ultimate completion date of May 20, 2025. This award is not set-aside and represents an open...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,000.61 firm fixed-price delivery order was issued under Amerisourcebergen's existing $999,999,999 Indefinite Delivery Contract with the DLA, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB25FCRWB
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,148.70 firm fixed price delivery order is for the supply of 1,000 capsules of Tamsulosin HCl 0.4 mg, a medication used to treat benign prostatic hyperplasia. The award has an ultimate completion date of November 25, 2024.

AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities. These large IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

Generated 2/21/25, 9:13 AM